Pro Share Advisors LLC I Mab Transaction History

Pro Share Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$12.54 - $46.93 $82,174 - $307,532	-6,553 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$45.28 - $74.5 $108,717 - $178,874	-2,401 Reduced 26.81%	6,553 $311,000
Q3 2021 Nov 12, 2021	BUY	$57.18 - $84.43 $184,062 - $271,780	3,219 Added 56.13%	8,954 $649,000
Q2 2021 Aug 13, 2021	BUY	$47.86 - $83.95 $274,477 - $481,453	5,735 New	5,735 $481,000

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $78.9M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.